Using Mastermind to automate the design of a pan-hematopoietic malignancy gene panel, Dr. Mark Kiel generated a set of biomarker candidates that includes 314 genes associated with leukemia and 311 genes associated with lymphoma. Each of these candidate biomarker genes were manually annotated based on likely mechanism of pathogenesis including mutation, expression, copy number and … Continue reading Evidence-Based Pan-Hematopoietic NGS Gene Panel
Tag: lymphoma NGS panel
This blog post has moved to a new home! Click here to view this post on the new Genomenon Blog.